Stay updated with breaking news from Peter Andersen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Among pharmaceutical heavyweights, Pfizer edged lower in choppy trading after the drugmaker's quarterly revenue fell short of Wall Street expectations, hit by declining sales of its COVID-19 products.
Wall Street was set to open lower on Tuesday ahead of economic data that could clear the air on a soft landing for the U.S. economy, while investors assessed mixed earnings from pharmaceutical heavyweights Merck and Pfizer. Merck rose 1.5% in premarket trading as it raised its full-year profit forecast after posting a smaller-than-expected second-quarter loss, while Pfizer slipped as it missed estimates for quarterly revenue. "So far things have played out well and we're looking forward to continued strengths and the outlook seems to be firming," said Peter Andersen, founder o...
* JPMorgan gains on Jefferies' upgrade ahead of results ...
Technological advancement in optical coherence tomography (OCT), one of the most significant types of light imaging, has been made in collaboration with the University of St Andrews.
Beloved children's book characters Elephant and Piggie take the Marriott Theatre stage while Chicago Shakespeare Theater presents an abridged version of "Disney's Beauty and the Beast," this week in Chicago-area theater.